ARCUS BIOSCIENCES INC (RCUS) Earnings History & Surprises

NYSE:RCUSUS03969F1093

Current stock price

20.25 USD
-1.16 (-5.42%)
At close:
20.25 USD
0 (0%)
After Hours:

RCUS Earnings overview

Past quarterly earnings results for ARCUS BIOSCIENCES INC (RCUS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.96
Revenue Estimate
27.497M

Last Reported

Most Recent
Release Date
Feb 25, 2026
Period
Q4 / 2025
EPS Reported
-$0.89
EPS Surprise
14.97%
Revenue Surprise
-9.40%

Beat Rate

Last 8 Quarters
75%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.89 -1.05 14.97% 13.59% 33M 36.425M -9.40% 26.92%
Q3 2025 -1.27 -1.34 4.95% -27.00% 26M 21.828M 19.11% -45.83%
Q2 2025 0.00 -1.15 100.00% 100.00% 160M 32.176M 397.27% 310.26%
Q1 2025 -1.14 -1.05 -8.41% -2,180.00% 28M 37.271M -24.87% -80.69%
Q4 2024 -1.03 -1.27 19.13% 4.63% 26M 29.478M -11.80% -16.13%
Q3 2024 -1.00 -1.08 7.78% -6.38% 48M 38.307M 25.30% 50.00%
Q2 2024 -1.02 -1.12 8.92% 1.92% 39M 26.125M 49.28% 34.48%
Q1 2024 -0.05 -0.97 94.85% 95.41% 145M 34.54M 319.80% 480.00%
Q4 2023 -1.08 -1.04 -3.39% -16.13% 31M 28.935M 7.14% -8.01%
Q3 2023 -0.94 -1.15 18.35% -4.44% 32M 27.828M 14.99% -4.76%
Q2 2023 -1.04 -1.12 7.19% -11.83% 29M 30.904M -6.16% 8.21%
Q1 2023 -1.09 -1.19 8.14% -13.54% 25M 25.467M -1.83% 38.89%
Q4 2022 -0.93 -1.09 14.53% -125.07% 33.7M 23.773M 41.76% -90.49%
Q3 2022 -0.90 -1.06 14.99% 18.92% 33.6M 22.325M 50.50% 253.68%
Q2 2022 -0.93 -0.96 3.18% 14.68% 26.8M 21.548M 24.37% 182.11%
Q1 2022 -0.96 -0.88 -9.30% 11.11% 18M 27.158M -33.72% 89.47%
Q4 2021 3.71 -0.76 589.04% 552.44% 354.5M 40.175M 782.39% 3,631.58%
Q3 2021 -1.11 -1.10 -1.15% -3,800.00% 9.5M 9.588M -0.92% -85.27%
Q2 2021 -1.09 -0.89 -22.28% -17.20% 9.5M 13.316M -28.66% 427.78%
Q1 2021 -1.08 -0.84 -27.86% -71.43% 9.5M 12.49M -23.94% 427.78%
Q4 2020 -0.82 -0.76 -7.29% - 9.5M 8.087M 17.47% -
Q3 2020 0.03 0.05 -41.18% - 64.5M 49.113M 31.33% -
Q2 2020 -0.93 -0.62 -49.04% - 1.8M 1.664M 8.17% -
Q1 2020 -0.63 -0.58 -9.44% - 1.8M 1.562M 15.24% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

RCUS EPS Q2Q GrowthRCUS EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q4/26 Q2/27 Q4/27 Q2/28 0 -1K -2K -3K

Revenue Historical Q2Q growth and Acceleration

RCUS Revenue Q2Q GrowthRCUS Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 Q1/28 Q3/28 0 1K 2K 3K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
27.88%
Max EPS beat (4)
100.00%
Min EPS beat (4)
-8.41%

Revenue beat statistics

Revenue beat (4)
2
Average Revenue beat (4)
95.53%
Max Revenue beat (4)
397.27%
Min Revenue beat (4)
-24.87%

Analysis

In the last 4 quarters, RCUS has beaten EPS estimates in 3 out of 4 releases
RCUS has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, RCUS has beaten the EPS estimates by 27.9% on average.
In the last 4 quarters, RCUS has beaten the revenue estimates by 95.5% on average.

ARCUS BIOSCIENCES INC / RCUS Earnings FAQ

When did ARCUS BIOSCIENCES INC (RCUS) report earnings last quarter?

ARCUS BIOSCIENCES INC (RCUS) last reported earnings on 2/25/2026.

Did RCUS stock beat earnings estimates in the most recent quarter?

ARCUS BIOSCIENCES INC (RCUS) beat EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does RCUS stock beat earnings estimates?

In the last 4 quarters, ARCUS BIOSCIENCES INC (RCUS) has beaten EPS estimates in 3 out of 4 releases.